Patient Registries Clinical Trials

PPD acquires unit, expands neurology capabilities for elderly patients

PPD adds clinical research unit with ‘strong’ recruiting track record to its portfolio, enabling studies on patient populations ‘more reflective’ of the products’ end-users.

Outsourcing Pharma   (December 2019)

Group names PPD best CRO provider

PPD was named Best CRO Provider at the sixth-annual World ADC Awards, according to a news release.

Greater Wilmington Business Journal  (November 2019)

The future of decentralized trials

Anna Long says the decentralizing of trials is likely to appeal to a greater diversity of patients, especially younger generations that have grown up with technology and the flexibility and interactivity it affords.

PharmaVOICE  (November 2019)

Building a better FSP

Krystina Fuge and Brian Ford discuss how resource forecasting, quality and training of staff, and innovation impact function service partnerships.

Applied Clinical Trials  (November 2019)

Inspiring the next generation

Ron Garrow notes that the industry’s efforts to constantly bend the time and cost curve of drug development, while remaining committed to quality and patient safety, mesh with the mindset of Generation Z.

PharmaVOICE  (November 2019)

Early detection for invisible patients

Dawie Wessels of AES and Clive Ballard of the University of Exeter Medical School discuss how innovative patient registries have become an important focus in the fight against Alzheimer’s disease.

International Clinical Trials  (November 2019)

After approval, can gene therapies achieve marketing success?

Having a well-designed plan that addresses the needs of all stakeholders — patients and their families, medical institutions, payers and manufacturers — will help drive successful outcomes.

PharmaVOICE   (November 2019)

Inclusion in clinical studies: PPD talks 'ethno-bridging'

PPD puts the spotlight on special patient populations by supporting clinical trials with Asian participants, preparing developers to expand into the Asian market.

Outsourcing Pharma  (November 2019)

Real-time hope for rare diseases

With advances in genomics sequencing combined with AI and other tools to speed up data analysis, the potential for quickly diagnosing and ultimately developing therapies that can treat patients with rare diseases in real time grows.

PharmaVOICE   (November 2019)

Integrated Scientific Advice: Helping to Optimize RWE Planning for Market Access

Real-world evidence (RWE) – what is its true value in health technology assessment? This is a question continually faced by biotech and pharmaceutical companies.

Pharmaceutical Executive  (November 2019)

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2019 Pharmaceutical Product Development, LLC. All rights reserved.